CLDN2
CLDN2 is a gene that encodes the claudin-2 protein in humans. Claudin-2 is a member of the claudin family, which plays a critical role in tight junctions. Tight junctions are essential components of the cell membrane that serve as barriers to regulate the passage of molecules and ions through the paracellular space between epithelial cells and endothelial cells. The presence of claudin-2 in these junctions is particularly important for the permeability properties of epithelial layers in the kidney, liver, and intestine.
Function[edit | edit source]
Claudin-2 forms ion-selective channels in tight junctions and is involved in the regulation of water and ion movement in epithelial tissues. It is highly expressed in the renal proximal tubule and the hepatic bile ducts, where it facilitates the transport of magnesium, calcium, and sodium ions. In the intestine, claudin-2 contributes to the absorption of nutrients and electrolytes, playing a vital role in maintaining homeostasis.
Clinical Significance[edit | edit source]
Alterations in the expression of the CLDN2 gene have been associated with various diseases. Overexpression of claudin-2 has been observed in several types of cancer, including colorectal cancer, hepatocellular carcinoma, and pancreatic cancer, suggesting a potential role in tumorigenesis and cancer progression. Additionally, variations in CLDN2 expression levels have been linked to inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, indicating its involvement in the pathophysiology of these conditions.
Genetic Regulation[edit | edit source]
The regulation of CLDN2 expression is complex and involves various transcription factors, cytokines, and signaling pathways. For instance, the tumor necrosis factor-alpha (TNF-α) and interleukin-13 (IL-13) have been shown to upregulate CLDN2 expression in certain cell types, contributing to the altered permeability observed in inflammatory conditions.
Potential Therapeutic Targets[edit | edit source]
Given its role in disease processes, CLDN2 presents a potential target for therapeutic intervention. Strategies to modulate claudin-2 levels or function could offer new avenues for the treatment of diseases associated with barrier dysfunction, such as IBD and certain cancers. Research into small molecule inhibitors and antibodies targeting claudin-2 is ongoing, with the aim of developing novel treatments that can restore normal barrier function or inhibit tumor growth.
See Also[edit | edit source]
References[edit | edit source]
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD